Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge
- 1 January 1993
- Vol. 11 (4) , 407-414
- https://doi.org/10.1016/0264-410x(93)90280-b
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal modelsVaccine, 1991
- Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cellsJournal of General Virology, 1990
- Expression of Glycoprotein D of Herpes Simplex Virus Type 1 in a Recombinant Baculovirus: Protective Responses and T Cell Recognition of the Recombinant-infected Cell ExtractsJournal of General Virology, 1989
- Large-Scale Insect Cell-Culture for Recombinant Protein ProductionNature Biotechnology, 1988
- Herpes Simplex Virus Glycoprotein Treatment of Recurrent Genital HerpesThe Journal of Infectious Diseases, 1988
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- Clinical efficacy of a herpes simplex subunit vaccineJournal of Medical Virology, 1985
- Antigen Engineering in Yeast: Synthesis and Assembly of Hybrid Hepatitis B Surface Antigen-Herpes Simplex 1 gD ParticlesNature Biotechnology, 1985
- DNA sequence of the Herpes simplex virus type 2 glycoprotein D geneGene, 1983
- Herpes Simplex Virus Type-1 Glycoprotein D Gene: Nucleotide Sequence and Expression in Escherichia coliScience, 1982